Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy R Peck

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Statistics and Computing|March 18, 2025
Estimation and model selection for finite mixtures of Tukey's <i>g</i>- &-<i>h</i> distributionsTingting Zhan, Misung Yi, Amy R Peck, et al.
Bioinformatics (Oxford, England)|December 4, 2020
Quantification of spatial tumor heterogeneity in immunohistochemistry staining imagesInna Chervoneva, Amy R Peck, Misung Yi, et al.
Molecular Cancer|June 14, 2013
Global profiling of prolactin-modulated transcripts in breast cancer in vivoTakahiro Sato, Thai H Tran, Amy R Peck, et al.
Breast Cancer Research and Treatment|February 15, 2011
Differential expression of arrestins is a predictor of breast cancer progression and survivalAllison M Michal, Amy R Peck, Thai H Tran, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 23, 2023
Quantile Index Biomarkers Based on Single-Cell Expression DataMisung Yi, Tingting Zhan, Amy R Peck, et al.
BMC Bioinformatics|July 22, 2023
Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry dataMisung Yi, Tingting Zhan, Amy R Peck, et al.
American Journal of Cancer Research|July 22, 2011
Signal transducer and activator of transcription-3 and breast cancer prognosisTakahiro Sato, Lynn Moretti Neilson, Amy R Peck, et al.
The American Journal of Pathology|October 19, 2010
PTP1B suppresses prolactin activation of Stat5 in breast cancer cellsKevin J Johnson, Amy R Peck, Chengbao Liu, et al.
Cancer Biology & Therapy|May 8, 2020
Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancersOlena Odnokoz, Pengfei Yu, Amy R Peck, et al.
Oncogene|August 19, 2020
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesisChristina Cho, Riddhita Mukherjee, Amy R Peck, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Statistics and Computing|March 18, 2025
Estimation and model selection for finite mixtures of Tukey's <i>g</i>- &-<i>h</i> distributionsTingting Zhan, Misung Yi, Amy R Peck, et al.
Bioinformatics (Oxford, England)|December 4, 2020
Quantification of spatial tumor heterogeneity in immunohistochemistry staining imagesInna Chervoneva, Amy R Peck, Misung Yi, et al.
Molecular Cancer|June 14, 2013
Global profiling of prolactin-modulated transcripts in breast cancer in vivoTakahiro Sato, Thai H Tran, Amy R Peck, et al.
Breast Cancer Research and Treatment|February 15, 2011
Differential expression of arrestins is a predictor of breast cancer progression and survivalAllison M Michal, Amy R Peck, Thai H Tran, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 23, 2023
Quantile Index Biomarkers Based on Single-Cell Expression DataMisung Yi, Tingting Zhan, Amy R Peck, et al.
BMC Bioinformatics|July 22, 2023
Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry dataMisung Yi, Tingting Zhan, Amy R Peck, et al.
American Journal of Cancer Research|July 22, 2011
Signal transducer and activator of transcription-3 and breast cancer prognosisTakahiro Sato, Lynn Moretti Neilson, Amy R Peck, et al.
The American Journal of Pathology|October 19, 2010
PTP1B suppresses prolactin activation of Stat5 in breast cancer cellsKevin J Johnson, Amy R Peck, Chengbao Liu, et al.
Cancer Biology & Therapy|May 8, 2020
Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancersOlena Odnokoz, Pengfei Yu, Amy R Peck, et al.
Oncogene|August 19, 2020
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesisChristina Cho, Riddhita Mukherjee, Amy R Peck, et al.
Pageof 3